Back to search

University of Alabama Birmingham

The Expression and Function of ICAM-2 in Neuroblastoma

Abstract

dc:description.abstract

Neuroblastoma (NB) is the most common extracranial solid tumor in childhood, accounting for 15% of all childhood cancer deaths. At the time of initial diagnosis, the majority of patients present with NB that has already metastasized. While initial remission is often achieved following treatment, roughly 50% of these patients will relapse and die from the development of intractable metastatic progression. Intercellular adhesion molecule-2 (ICAM-2) is a transmembrane glycoprotein, normally expressed only in endothelial cells and subsets of leukocytes. ICAM-2 expression in cancer cells had not been previously investigated, until our lab recently reported the novel finding of endogenous ICAM-2 expression in a subset of NB cell lines and primary NB tumor cells. Those NB cells that expressed ICAM-2 exhibited decreased motility in vitro and decreased metastatic potential in vivo. Furthermore, it was found that primary NB tumors found to express high levels of ICAM-2 correlated with favorable clinical features. The goal of this dissertation was to gain functional insight toward the mechanism in which ICAM-2 suppresses a metastatic phenotype. We approached this by synthesizing constructs encoding for structurally modified variants of ICAM-2, then expressing these constructs in NB cells. These modifications included altering the amino acid sequence of the cytoplasmic domain (CD), the extracellular domain, (ED) and the glycosylation status of the ICAM-2 protein. This is the first known attempt to comprehensively investigate the mechanism that ICAM-2 regulates in NB metastasis suppression. We compared the impact of ICAM-2 and each variant on NB cell adhesion, migration, anchorage-independent growth in soft agar, the formation localized and disseminated tumors in an in vivo metastasis model. The in vitro and in vivo phenotypes of cells expressing the ICAM-2 variants differed not only from cells expressing wild-type (WT) ICAM-2, but also no from cells expressing no detectable ICAM-2. Like the WT protein, ICAM-2 variants inhibited cell adhesion, migration and colony growth in vitro. However, unlike the WT protein, ICAM-2 variants did not completely suppress development of disseminated NB tumors in vivo. Furthermore, the data suggest that ICAM-2 may regulate the progression of NB metastasis through both alpha-actinin-dependent and alpha-actinin-independent pathways.

Degree

thesis:*
Level thesis:degree_level
Dissertation

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Feduska, Joseph
Contributors dc:contributor
  • Karina J Yoon
  • Robert Cam Van Waardenburg
  • Charles N Falany
  • Christopher Klug
  • Elizabeth Beierle Chen

Subjects

dc:subject × 4

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Feduska, Joseph. The Expression and Function of ICAM-2 in Neuroblastoma. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-collection/1634